The structure of HBsAg particles is not modified upon their adsorption on aluminium hydroxide gel. (Q45026767)

8 December 2017

title

The structure of HBsAg particles is not modified upon their adsorption on aluminium hydroxide gel. (English)

1 reference

8 December 2017

Andrey S Klymchenko

0 references

Vanille J Greiner

1 reference

8 December 2017

Frédéric Ronzon

1 reference

8 December 2017

Eric Larquet

1 reference

8 December 2017

Bernard Desbat

1 reference

8 December 2017

Catherine Estèves

1 reference

8 December 2017

Julie Bonvin

1 reference

8 December 2017

Frédéric Gréco

1 reference

8 December 2017

Catherine Manin

1 reference

8 December 2017

Yves Mély

1 reference

8 December 2017

language of work or name

English

0 references

publication date

15 June 2012

1 reference

8 December 2017

1 reference

8 December 2017

1 reference

8 December 2017

1 reference

8 December 2017

page(s)

5240-5245

1 reference

The molecular biology of the hepatitis B viruses

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.082

The virus of hepatitis, type B (first of two parts).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.082

Human hepatitis B vaccine from recombinant yeast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.082

Comparison between hepatitis B surface antigen (HBsAg) particles derived from mammalian cells (CHO) and yeast cells (Hansenula polymorpha): composition, structure and immunogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.082

Physical, chemical and immunological stability of CHO-derived hepatitis B surface antigen (HBsAg) particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.082

Hepatitis B small surface antigen particles are octahedral

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.082

Membrane structure of the hepatitis B virus surface antigen particle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.082

Hepatitis B surface antigen. Role of lipids in maintaining the structural and antigenic properties of protein components

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.082

Electron microscopic and solution X-ray scattering observations on the structure of hepatitis B surface antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.082

A topological model for hepatitis B surface antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.082

Maturation of recombinant hepatitis B virus surface antigen particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.082

Characterization of the lipid and protein organization in HBsAg viral particles by steady-state and time-resolved fluorescence spectroscopy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.082

Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.082

Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.082

Aluminum hydroxide adjuvants activate caspase-1 and induce IL-1beta and IL-18 release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.082

Activation of dendritic cells and induction of CD4(+) T cell differentiation by aluminum-containing adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.082

Mechanism of adsorption of hepatitis B surface antigen by aluminum hydroxide adjuvant.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.082

Initial events in interactions of blood with a foreign surface

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.082

The in vitro displacement of adsorbed model antigens from aluminium-containing adjuvants by interstitial proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.082

Preformulation studies--The next advance in aluminum adjuvant-containing vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.082

Spectroscopic characterization of antibodies adsorbed to aluminium adjuvants: correlation with antibody vaccine immunogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.082

Effects of adsorption to aluminum salt adjuvants on the structure and stability of model protein antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.082

Evidence for the denaturation of recombinant hepatitis B surface antigen on aluminium hydroxide gel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.082

Physiochemical and functional characterization of antigen proteins eluted from aluminum hydroxide adjuvant.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.082

Elutability of Proteins from Aluminum-Containing Vaccine Adjuvants by Treatment with Surfactants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.082

Effect of pH on the Elution of Model Antigens from Aluminum-Containing Adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.082

Relationship between tightness of binding and immunogenicity in an aluminum-containing adjuvant-adsorbed hepatitis B vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.082

Novel two-band ratiometric fluorescence probes with different location and orientation in phospholipid membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.082

Two-color fluorescent probes for imaging the dipole potential of cell plasma membranes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.082

Neutralization of hepatitis B virus infectivity by a murine monoclonal antibody: an experimental study in the chimpanzee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.082

Time-resolved fluorescence investigation of the human immunodeficiency virus type 1 nucleocapsid protein: influence of the binding of nucleic acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.082

Time-Resolved Fluorescence Allows Selective Monitoring of Trp30 Environmental Changes in the Seven-Trp-Containing Human Pancreatic Lipase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.082

Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine formulated with PLGA microspheres

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.082

Enhanced fluorescence of proteins and label-free bioassays using aluminum nanostructures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.082

Monitoring biophysical properties of lipid membranes by environment-sensitive fluorescent probes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.082

Simultaneous probing of hydration and polarity of lipid bilayers with 3-hydroxyflavone fluorescent dyes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.082

Secondary structures of proteins adsorbed onto aluminum hydroxide: infrared spectroscopic analysis of proteins from low solution concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.082

Effect of the strength of adsorption of hepatitis B surface antigen to aluminum hydroxide adjuvant on the immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.082

10.1016/J.VACCINE.2012.05.082

7 January 2021

Identifiers

DOI

1 reference

8 December 2017

1 reference